Trials / Completed
CompletedNCT00637130
Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost
Safety and IOP Lowering Efficacy of Low Dose Travoprost Ophthalmic Solutions Dosed BID Compared to TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 138 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and IOP-lowering efficacy of various low dose travoprost formulations in patients with open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost ophthalmic solution, 0.0008% | |
| DRUG | Travoprost ophthalmic solution, 0.001% | |
| DRUG | Travoprost ophthalmic solution, 0.0012% | |
| DRUG | TRAVATAN | |
| OTHER | Vehicle |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-01-01
- First posted
- 2008-03-17
- Last updated
- 2012-12-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00637130. Inclusion in this directory is not an endorsement.